The Impact of Osteopathic Manipulative Treatment on Pelvic Floor Dysfunction, Activity, and Gait in Female Runners
Elizabeth Perrero · NCT07812285
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–35 · Women only
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 10
- US sites recruiting
- 1
- Study start
- September 5, 2026
- Record last updated
- September 23, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
This study will examine whether osteopathic manipulative treatment (OMT) affects pelvic floor symptoms, physical activity, and running gait in female runners. Participants will complete six study sessions over 6 to 8 weeks that include questionnaires, gait assessments, and OMT. Participants will also use wearable devices to track physical activity throughout the study.
Being studied: Osteopathic Manipulative Treatment (OMT)
Conditions: Pelvic Floor Disfunction
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Healthy females assigned female at birth
- Run at least 15 miles per week
- English speaking
- No previous history of hip surgery
- Not currently breastfeeding or pregnant
- Not perimenopausal or menopausal
Exclusion Criteria
- Males
- Run less than 15 miles per week
- Non-English speaking
- History of hip surgery
- Currently breastfeeding or pregnant
- Perimenopausal or menopausal
Recruiting US locations
University of Kentucky
Lexington, KY 40506
Site contact: Elizabeth Perrero · 8593231100 · elizabeth.perrero@uky.edu
Study contacts (from the official record)
- Elizabeth Perrero · 8593231100 · elizabeth.perrero@uky.edu
Similar studies in Kentucky
All healthy volunteers studies in Kentucky →- RecruitingHealthy volunteersPhase 1
A Clinical Study of Novel Pneumococcal Vaccine V118C in Children (V118C-002)
Merck Sharp & Dohme LLC
- Location
- Louisville, KY + 14 other US sites
- Eligibility basics
- Ages 2 mo–1
- RecruitingHealthy volunteersPhase 1/Phase 2
Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
Xencor, Inc.
- Location
- Louisville, KY + 27 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteersPhase 1/Phase 2
Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta Virus
Gilead Sciences
- Location
- Louisville, KY + 4 other US sites
- Eligibility basics
- Ages 18–69
- RecruitingHealthy volunteersPhase 1/Phase 2
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Novartis Pharmaceuticals
- Location
- Louisville, KY + 18 other US sites
- Eligibility basics
- Ages 18–100